Literature DB >> 6260646

Properties of angiotensin-converting enzyme in intact cerebral microvessels.

P Brecher, A Tercyak, A V Chobanian.   

Abstract

Angiotensin-converting enzyme (ACE) was studied in preparations of microvessels isolated from rabbit cerebral cortex. Activity was determined by measuring the degradation of hippuryl-histidyl-leucine (Hip-His-Leu) by the intact microvessels in a physiological salt solution at pH 7.4. ACE activity was dependent on both substrate and chloride ion concentration and was inhibited by captopril in a manner similar to that observed previously with tissue homogenates. Angiotensin I was rapidly degraded by the intact microvessels, even in the presence of 10(-6)M captopril. An advantage of the methodology employed was the ability to pretreat the microvessels and then assess the effect of pretreatment by transfer to a postincubation assay system. Pretreatment with a hyperosmolar urea solution did not change ACE activity or cause release of ACE from the microvessels, although lactic dehydrogenase and lysosomal enzymes were released. Pretreatment with captopril caused a lag in the subsequent degradation of Hip-His-Leu, presumably reflecting dissociation of inhibitor from the cell-associated enzyme. ACE activity was unaffected by hypoxic or anoxic incubation conditions. The ability to measure ACE activity of the microvessels in vitro provides a unique opportunity to study the properties of the enzyme in intact cerebrovascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260646     DOI: 10.1161/01.hyp.3.2.198

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

Review 1.  Angiotensin and cerebral blood flow.

Authors:  J M Saavedra; Y Nishimura
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

2.  Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases.

Authors:  H Schweisfurth; S Schiöberg-Schiegnitz; W Kuhn; B Parusel
Journal:  Klin Wochenschr       Date:  1987-10-15

Review 3.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

4.  Budesonide, but not dexamethasone, blunted the response of aldosterone to renin elevation by suppressing angiotensin converting enzyme upon high-altitude exposure.

Authors:  Hui-Jie Li; Cheng-Rong Zheng; Guo-Zhu Chen; Jun Qin; Ji-Hang Zhang; Jie Yu; En-Hao Zhang; Lan Huang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-17       Impact factor: 1.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.